ID

33367

Beschreibung

Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma

Stichworte

Versionen (2)
  1. 06.11.18 06.11.18 -
  2. 06.12.18 06.12.18 -
Rechteinhaber

GSK group of companies

Hochgeladen am

6. Dezember 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837

Englisch

Study conclusion

1 Formulare  
  1. StudyEvent: ODM
    1. Study conclusion
Study conclusion details
Beschreibung

Study conclusion details

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Date of subject completion or withdrawal
Beschreibung

Date of subject completion or withdrawal

Datentyp

date

Alias
UMLS CUI [1]
C2983670
Was the subject withdrawn from the study?
Beschreibung

Was the subject withdrawn from the study?

Datentyp

boolean

Alias
UMLS CUI [1]
C0422727
If YES, complete primary reason for withdrawal
Beschreibung

If YES, complete primary reason for withdrawal

Alias
UMLS CUI-1
C0422727
UMLS CUI-2
C0392360
1. Adverse event
Beschreibung

record details on AE or SAE forms as appropriate)

Datentyp

boolean

Alias
UMLS CUI [1]
C0877248
2. Lack of efficacy
Beschreibung

Check all that apply. If none, select "No Subreasons"

Datentyp

text

Alias
UMLS CUI [1]
C0235828
3. Protocol Deviation
Beschreibung

Check all that apply. If none, select "No Subreasons"

Datentyp

text

Alias
UMLS CUI [1]
C1705236
4. Subject reached protocol defined stopping criteria
Beschreibung

4. Subject reached protocol defined stopping criteria

Datentyp

text

Alias
UMLS CUI [1,1]
C2746065
UMLS CUI [1,2]
C0243161
5. Study closed/terminated
Beschreibung

5. Study closed/terminated

Datentyp

boolean

Alias
UMLS CUI [1]
C2348570
6. Lost to Follow-Up
Beschreibung

6. Lost to Follow-Up

Datentyp

boolean

Alias
UMLS CUI [1]
C1302313
7. Investigator discretion, specify
Beschreibung

Select this reason if none of the other primary reasons are appropriate

Datentyp

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C0022423
UMLS CUI [1,3]
C2348235
8. Withdrew consent, specify
Beschreibung

Select this reason if none of the other primary reasons are appropriate

Datentyp

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2348235
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Study conclusion

1 Formulare
  1. StudyEvent: ODM
    1. Study conclusion
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study conclusion details
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C2983670 (UMLS CUI [1])
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item Group
If YES, complete primary reason for withdrawal
C0422727 (UMLS CUI-1)
C0392360 (UMLS CUI-2)
1. Adverse event
Item
1. Adverse event
boolean
C0877248 (UMLS CUI [1])
Item
2. Lack of efficacy
text
C0235828 (UMLS CUI [1])
2. Lack of efficacy
Code List
2. Lack of efficacy
CL Item
No subreasons (1)
CL Item
Exacerbation (2)
Item
3. Protocol Deviation
text
C1705236 (UMLS CUI [1])
3. Protocol Deviation
Code List
3. Protocol Deviation
CL Item
No subreasons (1)
CL Item
Pregnancy (2)
CL Item
Lack of adherence (3)
CL Item
Prohibited medication use (4)
Item
4. Subject reached protocol defined stopping criteria
text
C2746065 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Subject reached protocol defined stopping criteria
Code List
4. Subject reached protocol defined stopping criteria
CL Item
Yes (1)
CL Item
No (2)
CL Item
Liver function test abnormality (3)
5. Study closed/terminated
Item
5. Study closed/terminated
boolean
C2348570 (UMLS CUI [1])
6. Lost to Follow-Up
Item
6. Lost to Follow-Up
boolean
C1302313 (UMLS CUI [1])
7. Investigator discretion, specify
Item
7. Investigator discretion, specify
text
C0008961 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
8. Withdrew consent, specify
Item
8. Withdrew consent, specify
text
C1707492 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video